Prostate cancer Board decisions

The Veteran's claims for initial compensable ratings for erectile dysfunction, residuals of prostate cancer, and scars, status post prostatectomy are being remanded due to the need for additional examinations.

The Veteran's fecal incontinence is granted a 90 percent rating, effective December 9, 2014. The issue of whether the reduction from 100 percent to 40 percent for prostate cancer was proper remains pending and requires further examination.

The Board denied service connection for prostate cancer, finding that the Veteran did not have presumptive exposure to herbicides and there is no evidence of a direct relationship between his current condition and service.

The Veteran's claim for service connection for sleep apnea was denied as there is no evidence of current disability or in-service occurrence.,Service connection for ischemic neuropathy of the left upper extremity was also denied due to lack of a nexus between the condition and active duty service.,Prostate cancer, claimed as related to herbicide exposure, was not granted service connection because there was no evidence of herbicide exposure during service.

The Veteran's claims for service connection have been reopened and are now considered on their merits. The Board has found new and material evidence to support the reopening of these claims.

The Veteran's service-connected disabilities, including coronary artery disease, diabetes mellitus type 2, prostate cancer residuals, hypertension, tinnitus, erectile dysfunction, and bilateral hearing loss, rendered him unable to obtain or maintain gainful employment. His TDIU claim was granted effective from February 1, 2015.

The Veteran's prostate cancer was initially rated as noncompensable prior to January 29, 2014. From that date until May 26, 2016, he received a rating of 40 percent and from then on a rating of 60 percent.,PTSD was initially rated at 30 percent prior to July 3, 2018, and increased to 50 percent thereafter.

The Board denied the Veteran's claim for a compensable rating for prostate cancer residuals after May 1, 2015, finding that there were no residuals of his prostate cancer and thus discontinuing the 100 percent rating. The appeal is denied.

The Veteran's prostate cancer residuals are rated at 100% from November 12, 2018. The Board found that the Veteran does not meet criteria for a higher rating and denied his claims for increased ratings for other conditions.

The Board denied service connection for prostate cancer and migraine headaches, finding that the evidence did not support a causal relationship between these conditions and the Veteran's military service or exposure to contaminated water at Camp Lejeune.

The Veteran's TDIU and DEA benefits are granted with an effective date of January 13, 2012.

The Veteran's claim for service connection for PTSD is granted. The issues of compensation under 38 U.S.C. § 1151, increased rating for prostate cancer, and TDIU are remanded for further development.

The Board has determined that the issues of discontinuance of a 100 percent disability rating for prostate cancer, effective March 1, 2015, and entitlement to a disability rating in excess of 60 percent for residuals of prostate cancer from March 1, 2015 are remanded. The issue of entitlement to TDIU is also on appeal.

The Veteran's claim of service connection for prostate cancer is being remanded due to the need for a VA examination and consideration of additional evidence.

The Veteran's lumbar spine degenerative arthritis, right ear hearing loss, and bilateral tinnitus are all granted as service-connected.,As for the remaining conditions (asbestosis, prostate cancer, inguinal hernia, and urinary tract infection), they are remanded due to insufficient evidence in the record.

The Veteran's TDIU claim is remanded due to the need for additional medical examination and development of records.

The Board denied service connection for prostate cancer as the evidence did not show a link between the condition and service, including exposure to contaminated water or other chemicals.

The Board denied the Veteran's claims for service connection for COPD, an initial compensable rating for bilateral ear hearing loss, and an initial compensable rating for residuals of prostate cancer.

The Board has remanded the claims for lung cancer and prostate cancer as they are related to exposure to radiation, herbicide agents, and other environmental hazards during service. Further development is needed to assess the Veteran's exposure and provide a medical opinion.

The Veteran's prostate cancer is granted as service connected due to herbicide exposure at Ubon Royal Thai Air Force Base.